Agenda

February 27-March 1, 2025 | Salt Lake City, Utah

Register Now

Thursday February 27, 2025

  • 8:45 AM – 11:15 AM

    Meet the Masters Fellows Symposium (Non-CME)

    • Moderator
      • Eric PrystowskyMD
      • Greg Michaud
      • Melvin ScheinmanMD
  • 11:30 AM – 12:30 PM

    David E. Haines EP Fellows Research Competition (Non-CME)

    • Moderator
      • Sana Al-KhatibMD, MHS
  • 12:30 PM – 1:00 PM

    Networking Lunch Break

  • 1:00 PM – 1:45 PM

    Live Case 1 (Non-CME)

  • 1:45 PM – 2:30 PM

    Live Case 2 (Non-CME)

  • 2:30 PM – 3:15 PM

    Live Case 3 (Non-CME)

  • 3:15 PM – 3:45 PM

    Refreshment Break

  • 3:45 PM – 4:30 PM

    Live Case 4 (Non-CME)

  • 4:30 PM – 5:15 PM

    Live Case 5 (Non-CME)

  • 5:15 PM – 6:00 PM

    Live Case 6 (Non-CME)

  • 6:00 PM – 7:30 PM

    Exhibit Hall Opening Reception

Friday February 28, 2025

  • 7:00 AM – 8:00 AM

    Innovation Theater Breakfast (Non-CME)

  • +
    8:10 AM – 9:25 AM

    Session 1

    • Moderator
      • Hugh CalkinsMD
      • Melvin ScheinmanMD
    • 8:10 AM – 8:20 AM
      Welcome Remarks
    • 8:20 AM – 8:30 AM
      Addressing Major Knowledge Gaps in Atrial Fibrillation: The Top Five Priorities
    • 8:30 AM – 8:40 AM
      AF and Diastolic Dysfunction: Chicken and the Egg Dilemma
    • 8:40 AM – 8:50 AM
      Pulsed Field Ablation: A 10-Minute Update
    • 8:50 AM – 9:00 AM
      How Deep Learning Algorithms Predicting Atrial Fibrillation Can Enhance Prevention Strategies
    • 9:00 AM – 9:10 AM
      The OPTION Trial
    • 9:10 AM – 9:25 AM
      Discussion
  • +
    9:25 AM – 10:25 AM

    Session 2: Roundtable

    • 9:25 AM – 10:25 AM
      Roundtable: This is my Antiarrhythmic Drug Strategy Post-AF Ablation
  • 10:30 AM – 10:45 AM

    Exhibit Hall Refreshment Break

  • +
    10:50 AM – 11:55 AM

    Session 3

    • Moderator
      • David CallansMD
      • Marcos DaccarettMD, MSc
    • 11:00 AM – 11:10 AM
      Two-Year Follow-Up of the CASTLE-HTx Trial
    • 11:10 AM – 11:20 AM
      Comparing High Power Short Duration Ablation and Pulse Field Ablation: Which Approach for Which Patient?
    • 11:20 AM – 11:30 AM
      Effect of PFA on Left Atrial Structure and Function: Insights from TU CMR Database
    • 11:30 AM – 11:40 AM
      Wearables and Smartphones: Compliance in Atrial Fibrillation Monitoring
    • 11:40 AM – 11:55 AM
      Discussion
  • 12:00 PM – 1:00 PM

    Industry Supported Symposium Lunch (CME)

  • +
    1:05 PM – 2:00 PM

    Session 4

    • Moderator
      • John DayMD
      • Michael RileyMD
    • 1:05 PM – 1:15 PM
      A New Block in the CASTLE: Assessing Ablation versus Medical Therapy for HFpEF and AF
    • 1:15 PM – 1:25 PM
      Atrial Topology to Optimize Mapping and Ablation of Reentrant Atrial Tachycardia
    • 1:25 PM – 1:35 PM
      Atrial Myopathy and AFib: Show me the Causal Relationship in the Human Heart
    • 1:35 PM – 1:45 PM
      Importance of Preserving LA Function Post AF Ablation: Imaging Perspective
    • 1:45 PM – 2:00 PM
      Discussion
  • +
    2:00 PM – 3:00 PM

    Session 5

    • Moderator
      • Elaine WanMD
    • 2:00 PM – 2:10 PM
      The Upgrade of Dronedarone in the New AHA/ACC/ESC/HRS Guidelines: Impact on My Practice
    • 2:10 PM – 2:20 PM
      Pulsed Field Ablation Improved Safety of AF Ablation
    • 2:20 PM – 2:30 PM
      What Did I Learn From The AMAZE Trial: Implication For My Practice
    • 2:30 PM – 2:40 PM
      Association Between Obesity and Diastolic Dysfunction in AF Patient
    • 2:40 PM – 3:00 PM
      Discussion
  • 3:05 PM – 3:25 PM

    Exhibit Hall Refreshment Break

  • +
    3:30 PM – 4:45 PM

    Session 6

    • Moderator
      • Jared BunchMD
      • Narendra Kanuru
    • 3:30 PM – 3:40 PM
      Patient-Specific Multi-Physics Simulations: Impact of Fibrotic Changes on Left Atrial Hemodynamics
    • 3:40 PM – 3:50 PM
      Anticoagulation/Antiplatelet Therapy Post Left Atrial Appendage Occlusion
    • 3:50 PM – 4:00 PM
      Posterior Wall Isolation: Rational for SMILE Trial
    • 4:00 PM – 4:10 PM
      Utilizing Implantable Loop Recorders in the Management of Atrial Fibrillation
    • 4:10 PM – 4:20 PM
      Does Atrial Fibrillation Progression Correlate with the Progression of Atrial Myopathy?
    • 4:20 PM – 4:30 PM
      Genetic Relationship Between AF Risk and LA Dysfunction
    • 4:30 PM – 4:45 PM
      Discussion
  • +
    4:45 PM – 6:30 PM

    Session 7

    • Moderator
      • Douglas PackerMD
      • Usman SiddiquiMD FHRS
    • 4:45 PM – 5:35 PM
      Roundtable: When Tech Meets Tension: Managing Asymptomatic New Atrial Fibrillation Alerts
    • 5:35 PM – 5:45 PM
      Who Should Get an Additional Posterior Wall Isolation?
    • 5:45 PM – 5:55 PM
      Redefining Risk Stratification Tools for Major Bleeding in the Era of DOAC
    • 5:55 PM – 6:05 PM
      2024 EHRA/HRS/APHRS/LAHRS Expert Consensus on Catheter and Surgical Ablation of Atrial Fibrillation
    • 6:05 PM – 6:15 PM
      Lessons Learned from HRX 2024 for Implementing Digital Health in Atrial Fibrillation Management
    • 6:15 PM – 6:30 PM
      Discussion

Saturday March 01, 2025

  • 7:00 AM – 8:00 AM

    Innovation Theater Breakfast (Non-CME)

  • +
    8:10 AM – 9:30 AM

    Session 8

    • Moderator
      • Christian Sohns
      • Jorge RomeroMD
    • 8:10 AM – 8:20 AM
      Pulse Field Ablation for Redo-Ablation of Atrial Fibrillation
    • 8:20 AM – 8:30 AM
      Updates on New Left Atrial Appendage Closure Devices
    • 8:30 AM – 8:40 AM
      Neuromodulation for the Management of AF: The Targets
    • 8:40 AM – 8:50 AM
      Integrating AF Mapping Into the PFA Ablation Procedure
    • 8:50 AM – 9:00 AM
      AF in the Oncology Patient
    • 9:00 AM – 9:10 AM
      Electrocardiographic Deep Learning to Predict Left Atrial Myopathy
    • 9:10 AM – 9:30 AM
      Discussion
  • +
    9:30 AM – 10:50 AM

    Session 9: Roundtables

    • 9:30 AM – 10:10 AM
      Roundtable 1: Surgical MAZE and Hybrid Procedure: Patient Selection
    • 10:10 AM – 10:50 AM
      Roundtable 2: Bridging AI Research and Real-World Clinical Practice for AF Management: Practical Examples and Lessons Learned
  • 10:50 AM – 11:10 AM

    Exhibit Hall Refreshment Break

  • +
    11:15 AM – 12:30 PM

    Session 10

    • Moderator
      • Brent WilsonMD, PhD
      • Christian MahnkopfMD, PhD
    • 11:15 AM – 11:25 AM
      SGLT2i and GLP-1: Should It Be Prescribed for Every AF Patient?
    • 11:25 AM – 11:35 AM
      Patient Selection for Combined Procedure of Left Atrial Appendage Closure and Ablation in the Era of Pulse Field Ablation
    • 11:35 AM – 11:45 AM
      Managing Stroke Risk Post AF Ablation: Lessons Learned from Recent Trials
    • 11:45 AM – 11:55 AM
      How I Choose my Catheter to Ablate AF: A Real-World Cost Analysis
    • 11:55 AM – 12:05 PM
      MRI for the Detection of Lesions after Ablation
    • 12:05 PM – 12:15 PM
      Predicting LAA Thrombus Formation in Transthyretin Cardiac Amyloidosis: Imaging versus Clinical scores?
    • 12:15 PM – 12:30 PM
      Discussion
  • 12:45 PM – 1:45 PM

    Innovation Theater Lunch (Non-CME)

  • 1:45 PM – 2:05 PM

    Extended Exhibit Hall

  • +
    2:10 PM – 3:25 PM

    Session 11

    • Moderator
      • Ahmad Abdul KarimMD
      • Mina ChungMD
    • 2:10 PM – 2:20 PM
      Challenges with Reimbursement for AF Ablation: My Experience with CMS
    • 2:20 PM – 2:30 PM
      Obstructive Sleep Apnea in Patients Undergoing Catheter Ablation: Effect on Atrial Remodeling and AF Burden
    • 2:30 PM – 2:40 PM
      Top 5 AF Articles Published in JCE in 2024
    • 2:40 PM – 2:50 PM
      The Latest on Defining Atrial Myopathy Using Advanced MR Imaging
    • 2:50 PM – 3:00 PM
      Are Today's Wearables Suitable for Screening and Diagnosing AF?
    • 3:10 PM – 3:25 PM
      Discussion
  • 3:00 PM – 3:10 PM

    How do we Balance the Surge of Innovation with the Responsibility of Equitable, Ethical Care?

    • Speaker
      • Patricia BlakeFASAE,CAE
  • +
    3:25 PM – 4:30 PM

    Session 12

    • Moderator
      • Chris McGann
      • Hugh CalkinsMD
    • 3:35 PM – 3:45 PM
      Autonomic Modulation for the Treatment of Atrial Fibrillation and Heart Failure
    • 3:45 PM – 3:55 PM
      Atrial Myopathy in Stroke Prevention: Lessons Learned from the ARCADIA Trial
    • 3:55 PM – 4:05 PM
      Imaging-Based Computational Approaches for Atrial Fibrillation Assessment
    • 4:05 PM – 4:15 PM
      Safety Outcomes of Pulsed-Field Ablation
    • 4:15 PM – 4:30 PM
      Discussion
  • 3:25 PM – 3:35 PM

    Stroke Prevention in Atrial Fibrillation: Where are We Now and What's Next?

    • Speaker
      • Edip GurolMD, MSc
  • +
    4:30 PM – 5:30 PM

    Session 13: Roundtables

    • 4:30 PM – 5:10 PM
      Roundtable 1: Stroke Prevention in AF Patients: I Manage My Patients Independently of the CHA2DS2-VASc Score
    • 5:10 PM – 5:30 PM
      Roundtable 2: #AskWAF